Erasca closes upsized public stock offering raising USD 632.5 million
ERAS•Proceeds and intended use
Gross proceeds totaled about USD 632.5 million, before fees and expenses.
Net proceeds are earmarked for research and development programs, working capital, and general corporate purposes.
Offering closes with full over-allotment exercised
Erasca closed an upsized public offering of 36,142,857 common shares at USD 17.5 per share.
Underwriters exercised their option in full for 4,714,285 additional shares.
